ERIS LIFESCIENCES
|
|
BOM : 540596     NSE : ERIS     | |
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Good [Stock is Cheap] Debt : Low |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Mild Upward Pledged Shares : None or < 25% |
May 29,2023 |
Price(EOD): βΉ 635.30
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Pharmaceuticals & Drugs |
MCap: βΉ 8,640.08 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
ERIS LIFESCIENCES | 2.4% | 0.7% | -7.4% |
SUN PHARMACEUTICAL INDUSTRIES | 4% | -1.1% | 6.6% |
DIVIS LABORATORIES | 2.8% | 7.5% | -4.1% |
CIPLA | 2.7% | 4.6% | -2% |
DR REDDYS LABORATORIES | 2.2% | -7.4% | 4.1% |
TORRENT PHARMACEUTICALS | 0.8% | 4.6% | 31.3% |
ABBOTT INDIA | 1.8% | -1.2% | 20.3% |
ZYDUS LIFESCIENCES | 1% | -0.6% | 37.9% |
ALKEM LABORATORIES | 2.9% | -2.4% | 14.1% |
FUNDAMENTAL ANALYSIS OF ERIS LIFESCIENCES
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF ERIS LIFESCIENCES
 Ratio | Consolidated | |
---|---|---|
P/E P/B P/S |
23.09
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 374.16 Cr
[Latest Qtr - Mar2023 - Consolidated Results ] 3.93
P/B Calculated based on Book Value of Rs 2,195.99 Cr
[Latest Year - Mar2023 - Consolidated Results ] 5.13
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 1,685.15 Cr
[Latest Qtr - Mar2023 - Consolidated Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
-23% -33% -34% |
SHARE PRICE MOMENTUM OF ERIS LIFESCIENCES
ERIS LIFESCIENCES vs SENSEX
DEBT OF ERIS LIFESCIENCES
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2022 2021 2020 Avg_3yrs |
0 0 0 - |
0.02 0 0 0.01 |
[Last Annual Data : Mar2022]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF ERIS LIFESCIENCES
Pledged Promoter Shares |
0 % | |
---|---|---|
As on : Mar2023 | ||
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF ERIS LIFESCIENCES
Consolidated | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
-4.83% -13.34% -28.76% -38.66% |
31.66% 22.7% -11.06% -23.13% |
QtrlyTrend |
-4 | |
Latest Qtr: Mar2023 | ||
Quarterly Result Analysis → |
ERIS LIFESCIENCES related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
S&P BSE HEALTHCARE | 2.2% | 3.8% | 3.8% |
S&P BSE MIDSMALLCAP | 1.7% | 6.9% | 17.6% |
S&P BSE 500 | 1.7% | 5.2% | 13.8% |
S&P BSE ALLCAP | 1.7% | 5.3% | 13.9% |
S&P BSE 400 MIDSMALLCAP | 1.7% | 6.4% | 17.9% |
NSE Indices | 1W | 1M | 1Y |
---|---|---|---|
NIFTY MID SMALL400 | 1.9% | 6.5% | 18.5% |
NIFTY 500 | 1.7% | 5.2% | 14% |
NIFTY SMALLCAP250 | 1.2% | 6.2% | 14.4% |
You may also like the below Video Courses
FAQ about ERIS LIFESCIENCES
Is ERIS LIFESCIENCES good for long term investment?
As on May 29,2023, the Fundamentals of ERIS LIFESCIENCES look Strong and hence it may be good for long term investment! See Financial Performance of ERIS LIFESCIENCES . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is ERIS LIFESCIENCES UnderValued or OverValued?
As on May 29,2023, ERIS LIFESCIENCES is Under Valued based on the estimates of intrinsic value and hence may be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of ERIS LIFESCIENCES ?
As on May 29,2023, the Intrinsic Value of ERIS LIFESCIENCES is Rs. 943.38 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 823.82
Fair Value [Median EV / Sales Model] : Rs. 943.38
Fair Value [Median Price / Sales Model] : Rs. 957.15
Estimated Median Fair Value of ERIS LIFESCIENCES : Rs. 943.38
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.
Is ERIS LIFESCIENCES trading at a Premium or Discount?
As on May 29,2023, ERIS LIFESCIENCES is trading at a Discount of -33% based on the estimates of Median Intrinsic Value!